TGF-β reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells

Atherosclerosis

Volumn 155, Issue 1, 2001, Pages 79-85

  Zuckerman, Steven H ^a   Panousis, Constantinos ^a   Evans, Glenn ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Cytokines; Flow cytometry; Lipoproteins; Scavenger receptors

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; DEXAMETHASONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FOAM CELL; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLOW CYTOMETRY; FOAM CELLS; IMMUNOSUPPRESSIVE AGENTS; LIPOPROTEINS, HDL; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035112981     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00540-2     Document Type: Article

References (38)

1. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction and transfusion medicine
2. 3)
3. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion
4. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: Homology with human CD36
5. CD36 is a receptor for oxidized low density lipoprotein
6. Identification of a scavenger receptor SR-BI as a high density lipoprotein receptor
7. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
8. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain
9. Scavenger receptor BI promotes high density lipoprotein mediated cellular cholesterol efflux
10. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36
11. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators
12. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
13. Regulation of immune responses by TGF-β
14. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages
15. Transforming growth factor-beta complexes with thrombospondin
16. Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ
17. Construction and characterization of a normalized cDNA library
18. Molecular mechanisms of reverse cholesterol transport
19. Mechanism of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
20. An overview of reverse cholesterol transport
21. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
22. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
23. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics and the proximity of platelet-derived growth factor and transforming growth factor beta
24. Studies on TGF-beta 1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions
25. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-β
26. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta
27. Control of nitric oxide synthase expression by transforming growth factor-beta: Implications for homeostasis
28. Modulation of macrophage function by transforming growth factor beta, interleukin 4, and interleukin 10
29. Transforming growth factor beta 1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells
30. Expression of tissue inhibitor of metaloproteinases-3 in human atheroma and regulation in lesion-associated cells: A potential protective mechanism in plaque stability
31. Cytokine regulation of macrophage apo E secretion: Opposing effects of GM-CSF and TGF-β
32. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
33. Expression of human scavenger receptor class B type I in cultured human monocyte derived macrophages and atherosclerotic lesions
34. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages
35. Cellular responses to interferon-γ
36. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
37. Induction of inhibitory SMAD6 and SMAD7 mRNA by TGF-β family members
38. CD36, A novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta